Compounds > silybin
Page last updated: 2024-08-23

silybin and ascorbic acid

silybin has been researched along with ascorbic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, YB; Gong, JX; Huang, KX; Li, HB; Li, XK; Qu, J; Spencer, S; Tao, QF; Wang, F; Wu, XM; Wu, YH; Yang, LX; Zeng, S; Zhao, Y1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Bartalis, J; Halaweish, FT1
Abourashed, EA; Khan, IA; Mikell, JR1
Biler, M; Chantemargue, B; Jezova-Kalachova, L; Křen, V; Kuzma, M; Pyszková, M; Riva, S; Trouillas, P; Ulrichová, J; Vacek, J; Valentová, K; Vavříková, E; Vrba, J1
Decker, M; Gunesch, S; Högger, P; Huang, G; Lang, F; Maher, P; Roa, J; Sabaté, R; Schramm, S1

Other Studies

6 other study(ies) available for silybin and ascorbic acid

ArticleYear
Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives.
    Journal of medicinal chemistry, 2009, Dec-10, Volume: 52, Issue:23

    Topics: Alkenes; Alzheimer Disease; Amides; Animals; Drug Design; Free Radical Scavengers; Humans; Iron Chelating Agents; Lipid Peroxidation; Liver; Male; Models, Molecular; Molecular Conformation; Neurons; Neuroprotective Agents; Parkinson Disease; PC12 Cells; Rats; Silymarin; Structure-Activity Relationship; Xanthine Oxidase

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Animals; Cell Line; Cell Proliferation; Cucurbitacins; Fibrosis; Hep G2 Cells; Hepatic Stellate Cells; Humans; Hydrophobic and Hydrophilic Interactions; Liver; Protective Agents; Quantitative Structure-Activity Relationship; Rats

2011
Bioconversion of silybin to phase I and II microbial metabolites with retained antioxidant activity.
    Bioorganic & medicinal chemistry, 2012, May-01, Volume: 20, Issue:9

    Topics: Antioxidants; Beauveria; Cunninghamella; Magnetic Resonance Spectroscopy; Molecular Conformation; Silybin; Silymarin

2012
Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
    European journal of medicinal chemistry, 2017, Feb-15, Volume: 127

    Topics: Antioxidants; Cell Membrane; Cytoprotection; Electron Transport; Enzymes, Immobilized; Flavonolignans; Fungal Proteins; Hep G2 Cells; Humans; Lipase; Lipid Peroxidation; Liver; Molecular Conformation; Molecular Dynamics Simulation; Silybin; Silymarin

2017
Regioselective synthesis of 7-O-esters of the flavonolignan silibinin and SARs lead to compounds with overadditive neuroprotective effects.
    European journal of medicinal chemistry, 2018, Feb-25, Volume: 146

    Topics: Amyloid beta-Peptides; Animals; Antioxidants; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Esters; Flavonolignans; Humans; Molecular Structure; Neuroprotective Agents; PC12 Cells; Protein Aggregates; Rats; Silybin; Silymarin; Stereoisomerism; Structure-Activity Relationship

2018